Page 21 - GPD-4-3
P. 21

Gene & Protein in Disease                                      Targeting cathepsins during cancer development



            32.  Delbridge AR, Strasser A. The BCL-2 protein family,   43.  Kleer CG, Bloushtain-Qimron N, Chen YH, et al. Epithelial
               BH3-mimetics and cancer therapy.  Cell Death Differ.   and stromal cathepsin K and CXCL14 expression in breast
               2015;22(7):1071-1080.                              tumor progression. Clin Cancer Res. 2008;14(17):5357-5367.
               doi: 10.1038/cdd.2015.50                           doi: 10.1158/1078-0432.CCR-08-0732
            33.  Merino D, Kelly GL, Lessene G, Wei AH, Roberts AW,   44.  Gocheva V, Zeng W, Ke D, et al. Distinct roles for cysteine
               Strasser A. BH3-mimetic drugs: Blazing the trail for new   cathepsin genes in multistage tumorigenesis.  Genes Dev.
               cancer medicines. Cancer Cell. 2018;34(6):879-891.  2006;20(5):543-556.
               doi: 10.1016/j.ccell.2018.11.004                   doi: 10.1101/gad.1407406
            34.  Turk V, Stoka V, Vasiljeva O, et al. Cysteine cathepsins: From   45.  Jedeszko C, Sloane BF. Cysteine cathepsins in human cancer.
               structure, function and regulation to new frontiers. Biochim   Biol Chem. 2004;385(11):1017-1027.
               Biophys Acta. 2012;1824(1):68-88.
                                                                  doi: 10.1515/BC.2004.132
               doi: 10.1016/j.bbapap.2011.10.002
                                                               46.  Ebert MP, Kruger S, Fogeron ML, et al. Overexpression
            35.  Pogorzelska A, Zolnowska B, Bartoszewski R. Cysteine   of  cathepsin  B  in gastric cancer  identified by  proteome
               cathepsins as a prospective target for anticancer therapies-  analysis. Proteomics. 2005;5(6):1693-1704.
               current progress and prospects. Biochimie. 2018;51:85-106.
                                                                  doi: 10.1002/pmic.200401030
               doi: 10.1016/j.biochi.2018.05.023
                                                               47.  Bengsch F, Buck A, Gunther SC, et al. Cell type-dependent
            36.  Kozlowski L, Rucinska M, Wojtukiewicz MZ. Metastases   pathogenic functions of overexpressed human cathepsin
               of malignant melanoma of unknown primary site: An   B in murine breast cancer progression.  Oncogene.
               important diagnostic and therapeutic problem. Pol Merkur   2014;33(36):4474-4484.
               Lekarski. 2000;8(49):486-488.
                                                                  doi: 10.1038/onc.2013.395
            37.  Sloane BF, Dunn JR, Honn KV. Lysosomal cathepsin   48.  Qin G, Cai Y, Long J, et al. Cathepsin L is involved in
               B: Correlation with metastatic potential.  Science.
               1981;212(4499):1151-1153.                          proliferation and invasion of breast cancer cells. Neoplasma.
                                                                  2016;63(1):30-36.
               doi: 10.1126/science.7233209
                                                                  doi: 10.4149/neo_2016_004
            38.  Dian D, Vrekoussis T, Shabani N, et al. Expression of   49.  Wang W, Long L, Wang L, et al. Knockdown of Cathepsin L
               cathepsin-D  in primary breast  cancer  and corresponding
               local recurrence or metastasis: An immunohistochemical   promotes radiosensitivity of glioma stem cells both in vivo
               study. Anticancer Res. 2012;32(3):901-905.         and in vitro. Cancer Lett. 2016;71(2):274-284.
                                                                  doi: 10.1016/j.canlet.2015.12.012
            39.  Fujise N, Nanashim A, Taniguchi Y, et al. Prognostic impact
               of cathepsin B and matrix metalloproteinase-9 in pulmonary   50.  Mehrotra S, Wickremesekera SK, Brasch HD, et al. Expression
               adenocarcinomas by immunohistochemical study.  Lung   and localization of cathepsins B, D and G in cancer stem
               Cancer. 2000;27(1):19-26.                          cells in liver metastasis from colon adenocarcinoma. Front
                                                                  Surg. 2018;5:40.
               doi: 10.1016/s0169-5002(99)00088-4
                                                                  doi: 10.3389/fsurg.2018.00040
            40.  Pruitt FL, He Y, Franco OE, Jiang M, Cates JM, Hayward
               SW. Cathepsin D acts as an essential mediator to promote   51.  Featherston T, Marsh RW, van Schaijik B, Brasch HD, Tan ST,
               malignancy of benign prostatic epithelium.  Prostate.   Itinteang T. Expression and localization of cathepsins B, D,
               2013;73(5):476-488.                                and G in two cancer stem cell subpopulations in moderately
                                                                  differentiated oral tongue squamous cell carcinoma. Front
               doi: 10.1002/pros.22589
                                                                  Med (Lausanne). 2017;4:100.
            41.  Krueger  S,  Kalinski  T,  Wolf  H,  Kellner  U,  Roessner  A.
               Interactions between human colon carcinoma cells,      doi: 10.3389/fmed.2017.00100
               fibroblasts and monocytic cells in coculture--regulation   52.  Breznik B, Limbaeck Stokin C, Kos J, et al. Cysteine cathepsins
               of cathepsin B expression and invasiveness.  Cancer Lett.   B, X and K expression in peri-arteriolar glioblastoma stem
               2005;223(2):313-322.                               cell niches. J Mol Histol. 2018;9(5):481-497.
               doi: 10.1016/j.canlet.2004.09.050                  doi: 10.1007/s10735-018-9787-y
            42.  Sivaparvathi M, Sawaya R, Gokaslan ZL, Chintala SK, Rao JS.   53.  Sui H, Shi C, Yan Z, Wu M. Overexpression of Cathepsin L
               Expression and the role of cathepsin H in human glioma   is associated with chemoresistance and invasion of epithelial
               progression and invasion. Cancer Lett. 1996;104(1):121-126.  ovarian cancer. Oncotarget. 2016;(29):45995-46001.
               doi: 10.1016/0304-3835(96)04242-5                  doi: 10.18632/oncotarget.10276


            Volume 4 Issue 3 (2025)                         10                              doi: 10.36922/gpd.4768
   16   17   18   19   20   21   22   23   24   25   26